Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer A comparative plan analysis

被引:7
|
作者
Song, C. [2 ,4 ]
Pyo, H. [1 ]
Kim, J. [1 ]
Lim, Y. K. [2 ]
Kim, W. C. [3 ]
Kim, H. J. [4 ]
Kim, D. W. [2 ]
Cho, K. H. [2 ]
机构
[1] Sungkyunkwan Univ, Dept Radiat Oncol, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
[2] Res Inst & Hosp, Proton Therapy Ctr, Natl Canc Ctr, Goyang, South Korea
[3] Inha Univ, Dept Radiat Oncol, Sch Med, Inchon, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
关键词
Non-small cell lung cancer; Helical tomotherapy; Intensity-modulated radiotherapy; Radiation pneumonitis; Radiation dosage; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; DOSE-ESCALATION; IMRT TECHNIQUES; NORMAL TISSUE; PNEUMONITIS; IRRADIATION; TOXICITY; RISK; CHEMOTHERAPY;
D O I
10.1007/s00066-012-0159-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To compare helical tomotherapy (HT) and conventional intensity-modulated radiotherapy (IMRT) using a variety of dosimetric and radiobiologic indexes in patients with locally advanced non-small cell lung cancer (LA-NSCLC). A total of 20 patients with LA-NSCLC were enrolled. IMRT plans with 4-6 coplanar beams and HT plans were generated for each patient. Dose distributions and dosimetric indexes for the tumors and critical structures were computed for both plans and compared. Both modalities created highly conformal plans. They did not differ in the volumes of lung exposed to > 20 Gy of radiation. The average mean lung dose, volume receiving a parts per thousand yenaEuro parts per thousand 30 Gy, and volume receiving a parts per thousand yenaEuro parts per thousand 10 Gy in HT planning were 18.3 Gy, 18.5%, and 57.1%, respectively, compared to 19.4 Gy, 25.4%, and 48.9%, respectively, with IMRT (p = 0.004, p < 0.001, and p < 0.001). The differences between HT and IMRT in lung volume receiving a parts per thousand yenaEuro parts per thousand 10-20 Gy increased significantly as the planning target volume (PTV) increased. For 6 patients who had PTV greater than 700 cm(3), IMRT was superior to HT for 5 patients in terms of lung volume receiving a parts per thousand yenaEuro parts per thousand 5-20 Gy. The integral dose to the entire thorax in HT plans was significantly higher than in IMRT plans. HT gave significantly better control of mean lung dose and volume receiving a parts per thousand yenaEuro parts per thousand 30-40 Gy, whereas IMRT provided better control of the lung volume receiving a parts per thousand yenaEuro parts per thousand 5-15 Gy and the integral dose to entire thorax. In most patients with PTV greater than 700 cm(3), IMRT was superior to HT in terms of lung volume receiving a parts per thousand yenaEuro parts per thousand 5-20 Gy. It is therefore advised that caution should be exercised when planning LA-NSCLC using HT.
引用
收藏
页码:901 / 909
页数:9
相关论文
共 50 条
  • [21] Radiotherapy for inoperable non-small cell lung cancer using helical tomotherapy
    Monaco, Alessia
    Caruso, Cristina
    Giammarino, Daniela
    Cianciulli, Michele
    Pressello, Maria Cristina
    Donato, Vittorio
    TUMORI, 2012, 98 (01) : 86 - 89
  • [22] Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer
    Ling, Diane C.
    Hess, Clayton B.
    Chen, Allen M.
    Daly, Megan E.
    CLINICAL LUNG CANCER, 2016, 17 (01) : 18 - 23
  • [23] Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer
    Abe, Takanori
    Iino, Misaki
    Saito, Satoshi
    Aoshika, Tomomi
    Ryuno, Yasuhiro
    Ohta, Tomohiro
    Igari, Mitsunobu
    Hirai, Ryuta
    Kumazaki, Yu
    Miura, Yu
    Kaira, Kyoichi
    Kagamu, Hiroshi
    Noda, Shin-ei
    Kato, Shingo
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (05) : 894 - 900
  • [24] Feasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT
    He, Jian
    Huang, Yan
    Chen, Yixing
    Shi, Shiming
    Ye, Luxi
    Hu, Yong
    Zhang, Jianying
    Zeng, Zhaochong
    JOURNAL OF THORACIC DISEASE, 2016, 8 (05) : 862 - 871
  • [25] Fractures of thoracic vertebrae in patients with locally advanced non-small cell lung carcinoma treated with intensity modulated radiotherapy
    Uyterlinde, Wilma
    Chen, Chun
    Belderbos, Jose
    Sonke, Jan-Jakob
    Lange, Charlotte
    de Bois, Josien
    van den Heuvel, Michel
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (03) : 437 - 441
  • [26] Optimising Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer with Volumetric Intensity-modulated Arc Therapy-A Planning Study
    Brock, J.
    Bedford, J.
    Partridge, M.
    McDonald, F.
    Ashley, S.
    McNair, H. A.
    Brada, M.
    CLINICAL ONCOLOGY, 2012, 24 (01) : 68 - 75
  • [27] Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-) radiotherapy using IMRT or VMAT
    Wijsman, Robin
    Dankers, Frank
    Troost, Esther G. C.
    Hoffmann, Aswin L.
    van der Heijden, Erik H. F. M.
    de Geus-Oei, Lioe-Fee
    Bussink, Johan
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) : 295 - 299
  • [28] Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer
    Pollom, Erqi L.
    Qian, Yushen
    Durkee, Ben Y.
    von Eyben, Rie
    Maxim, Peter G.
    Shultz, David B.
    Gensheimer, Michael
    Diehn, Maximilian
    Loo, Billy W., Jr.
    CLINICAL LUNG CANCER, 2016, 17 (06) : 588 - 594
  • [29] Safety and Efficacy of Intensity-Modulated Stereotactic Body Radiotherapy Using Helical Tomotherapy for Lung Cancer and Lung Metastasis
    Nagai, Aiko
    Shibamoto, Yuta
    Yoshida, Masanori
    Inoda, Koji
    Kikuchi, Yuzo
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] Routine Use of Intensity-Modulated Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Is Neither Choosing Wisely Nor Personalized Medicine Reply
    Chun, Stephen G.
    Hu, Chen
    Bradley, Jeffrey D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (13) : 1493 - +